Dawnrays Pharmaceutical (Holdings) Limited (SEHK: 2348)
Health Care · Pharmaceuticals · HK
HK$0.96
-0.52% today · -22.6% 1Y
Dawnrays Pharmaceutical (Holdings) Limited (SEHK: 2348) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $184.28M and employs 1,074 people.
Over the last twelve months the share price has lost 22.6%, trading between 0.95 and 1.26.
Tweenvest scores Dawnrays Pharmaceutical (Holdings) Limited across four factors: quality 85/100, value 74/100, growth 32/100, dividend 50/100. Its strongest factor is quality.
2348 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $184.28M
- Revenue (TTM)
- $168.75M
- P/E
- 5.46
- EPS
- 0.15
- Dividend yield
- 6.56%
- Beta (5Y)
- 0.26
- 52-week high
- HK$1.26
- 52-week low
- HK$0.95
- Avg volume (3M)
- —
- Shares outstanding
- 1.51B
- Employees
- 1,074
- Next earnings
- —
About Dawnrays Pharmaceutical (Holdings) Limited
Dawnrays Pharmaceutical (Holdings) Limited operates as an investment holding company, primarily engaged in the creation, production, and global distribution of generic pharmaceutical medicines, with a focus on Mainland China and international markets. Its operations are divided into two main divisions: Intermediates and Bulk Medicines, and Finished Drugs. The company's diverse product portfolio features a range of antibiotics, including pharmaceutical intermediates, bulk active ingredients, powdered formulations for injection, and oral antibiotic preparations. Furthermore, Dawnrays offers specialized medications addressing various bodily systems and conditions, such as those for cardiovascular health, allergies, Hepatitis B Virus (HBV), digestive and urinary issues, antipyretic-analgesic (fever and pain relief), respiratory ailments, and endocrine disorders. These system-specific drugs are dispensed in familiar forms like tablets, capsules, and granules. Founded in 1995, the firm maintains its headquarters in Wan Chai, Hong Kong, and is a subsidiary of Fortune United Group Limited.
- ISIN
- KYG2687M1006
- Founded
- 1995
- Listed since
- Jul 11, 2003
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| NGL Fine-Chem LimitedBSE: 524774 | $186.76M | Rs2,925.65 | +0.01% |
| MINAPHARM PharmaceuticalsCASE: MIPH | $186.58M | EGP829.40 | +2.08% |
| NervGen Pharma Corp.NasdaqCM: NGEN | $186.01M | $1.73 | -2.81% |
| Yoda Pharmaceuticals Inc.TPEX: 7829 | $185.57M | NT$59.70 | +1.02% |
| Formosa Laboratories, Inc.TWSE: 4746 | $184.10M | NT$48.95 | +1.77% |
| Alar Pharmaceuticals Inc.TPEX: 6785 | $184.05M | NT$88.10 | -6.97% |
| Orient Pharma Co., Ltd.TPEX: 4166 | $183.94M | NT$24.20 | -0.82% |
| Samjin Pharmaceuticals Co., Ltd.KOSE: A005500 | $183.27M | ₩20,100.00 | +5.35% |
Figures last refreshed Oct 11, 2026.